CD14++CD16+ monocytes are enriched by glucocorticoid treatment and are functionally attenuated in driving effector T cell responses

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5150-5160

  Liu, Baoying ^a   Dhanda, Ashwin ^b,c   Hirani, Sima ^a   Williams, Emily L ^b,c   Sen, H Nida ^a   Estrada, Fernando Martinez ^d   Ling, Diamond ^a   Thompson, Ian ^a   Casady, Megan ^a   Li, Zhiyu ^a   Si, Han ^a   Tucker, William ^a   Wei, Lai ^a   Jawad, Shayma ^a   Sura, Amol ^a   Dailey, Jennifer ^a   Hannes, Susan ^a   Chen, Ping ^a   Chien, Jason L ^a   Gordon, Siamon ^d   Lee, Richard W J ^b,c   Nussenblatt, Robert B ^a   more..

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CYCLOSPORIN; GAMMA INTERFERON; GLUCOCORTICOID; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 17; METHOTREXATE; MYCOPHENOLATE MOFETIL; DEXAMETHASONE; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IL10 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; AUTOIMMUNE UVEITIS; BLOOD; CD14++ CD16+ MONOCYTE; CD4+ T LYMPHOCYTE; CELL SUBPOPULATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG EFFECT; EFFECTOR CELL; FEMALE; FKBP5 GENE; GENE; GENE EXPRESSION; GILZ GENE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MKP 1 GENE; MONOCYTE; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; SGK GENE; T LYMPHOCYTE ACTIVATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; TH1 CELL; UVEITIS;

ANTIGENS, CD14; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DEXAMETHASONE; GLUCOCORTICOIDS; GPI-LINKED PROTEINS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; RECEPTORS, IGG; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; UVEITIS;

EID: 84929612296     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402409     Document Type: Article

References (48)

1. Evans, H. G., N. J. Gullick, S. Kelly, C. Pitzalis, G. M. Lord, B. W. Kirkham, and L. S. Taams. 2009. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc. Natl. Acad. Sci. USA 106: 6232-6237.
2. Evans, H. G., T. Suddason, I. Jackson, L. S. Taams, and G. M. Lord. 2007. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. USA 104: 17034-17039.
3. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646.
4. Ziegler-Heitbrock, L., P. Ancuta, S. Crowe, M. Dalod, V. Grau, D. N. Hart, P. J. Leenen, Y. J. Liu, G. MacPherson, G. J. Randolph, et al. 2010. Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-e80. Available at: http://www.bloodjournal.org/content/116/16/e74.
5. Wong, K. L., J. J. Tai, W. C. Wong, H. Han, X. Sem, W. H. Yeap, P. Kourilsky, and S. C. Wong. 2011. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118: e16-e31. Available at: http://www.bloodjournal.org/content/118/ 5/e16.
6. Zawada, A. M., K. S. Rogacev, B. Rotter, P. Winter, R. R. Marell, D. Fliser, and G. H. Heine. 2011. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118: e50-e61. Available at: http://www. bloodjournal.org/content/118/12/e50.
7. Skrzeczyńska-Moncznik, J., M. Bzowska, S. Loseke, E. Grage-Griebenow, M. Zembala, and J. Pryjma. 2008. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand. J. Immunol. 67: 152-159.
8. Fingerle, G., A. Pforte, B. Passlick, M. Blumenstein, M. Ströbel, and H. W. Ziegler-Heitbrock. 1993. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82: 3170-3176.
9. Zimmermann, H. W., S. Seidler, J. Nattermann, N. Gassler, C. Hellerbrand, A. Zernecke, J. J. Tischendorf, T. Luedde, R. Weiskirchen, C. Trautwein, and F. Tacke. 2010. Functional contribution of elevated circulating and hepatic nonclassical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS ONE 5: e11049. Available at: http://journals.plos.org/plosone/article?id=10.1371/ journal.pone.0011049.
10. Hepburn, A. L., J. C. Mason, and K. A. Davies. 2004. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) 43: 547-554.
11. Katayama, K., T. Matsubara, M. Fujiwara, M. Koga, and S. Furukawa. 2000. CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin. Exp. Immunol. 121: 566-570.
12. Kawanaka, N., M. Yamamura, T. Aita, Y. Morita, A. Okamoto, M. Kawashima, M. Iwahashi, A. Ueno, Y. Ohmoto, and H. Makino. 2002. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 46: 2578-2586.
13. Mizuno, K., T. Toma, H. Tsukiji, H. Okamoto, H. Yamazaki, K. Ohta, K. Ohta, Y. Kasahara, S. Koizumi, and A. Yachie. 2005. Selective expansion of CD16highCCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation. Clin. Exp. Immunol. 142: 461-470.
14. Okamoto, H., K. Mizuno, and T. Horio. 2003. Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients. J. Dermatol. 30: 503-509.
15. Rossol, M., S. Kraus, M. Pierer, C. Baerwald, and U. Wagner. 2012. The CD14 (bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum. 64: 671-677.
16. Schlitt, A., G. H. Heine, S. Blankenberg, C. Espinola-Klein, J. F. Dopheide, C. Bickel, K. J. Lackner, M. Iz, J. Meyer, H. Darius, and H. J. Rupprecht. 2004. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb. Haemost. 92: 419-424.
17. Strauss-Ayali, D., S. M. Conrad, and D. M. Mosser. 2007. Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 82: 244-252.
18. Wijngaarden, S., J. A. van Roon, J. W. Bijlsma, J. G. van de Winkel, and F. P. Lafeber. 2003. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs. Rheumatology (Oxford) 42: 681-688.
19. Rosenbaum, J. T., and H. W. Kim. 2013. Innate immune signals in autoimmune and autoinflammatory uveitis. Int. Rev. Immunol. 32: 68-75.
20. Fang, J., D. Fang, P. B. Silver, F. Wen, B. Li, X. Ren, Q. Lin, R. R. Caspi, and S. B. Su. 2010. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Invest. Ophthalmol. Vis. Sci. 51: 3092-3099.
21. Su, S. B., P. B. Silver, R. S. Grajewski, R. K. Agarwal, J. Tang, C. C. Chan, and R. R. Caspi. 2005. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J. Immunol. 175: 6303-6310.
22. Willermain, F., J. T. Rosenbaum, B. Bodaghi, H. L. Rosenzweig, S. Childers, T. Behrend, G. Wildner, and A. D. Dick. 2012. Interplay between innate and adaptive immunity in the development of non-infectious uveitis. Prog. Retin. Eye Res. 31: 182-194.
23. Mulherin, D., O. Fitzgerald, and B. Bresnihan. 1996. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 39: 115-124.
24. Wijbrandts, C. A., C. E. Vergunst, J. J. Haringman, D. M. Gerlag, T. J. Smeets, and P. P. Tak. 2007. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum. 56: 3869-3871.
25. Geyer, M., and U. Müller-Ladner. 2010. Actual status of antiinterleukin-1 therapies in rheumatic diseases. Curr. Opin. Rheumatol. 22: 246-251.
26. Ito, H. 2003. Anti-interleukin-6 therapy for Crohn's disease. Curr. Pharm. Des. 9: 295-305.
27. Wijbrandts, C. A., M. G. Dijkgraaf, M. C. Kraan, M. Vinkenoog, T. J. Smeets, H. Dinant, K. Vos, W. F. Lems, G. J. Wolbink, D. Sijpkens, et al. 2008. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium. Ann. Rheum. Dis. 67: 1139-1144.
28. Woodrick, R., and E. M. Ruderman. 2010. Anti-interleukin-6 therapy in rheumatoid arthritis. Bull. NYU Hosp. Jt. Dis. 68: 211-217.
29. Ehrchen, J., L. Steinmüller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkötter, and J. Roth. 2007. Glucocorticoids induce differentiation of a specifically activated, antiinflammatory subtype of human monocytes. Blood 109: 1265-1274.
30. Tsianakas, A., G. Varga, K. Barczyk, G. Bode, N. Nippe, N. Kran, J. Roth, T. A. Luger, J. Ehrchen, and C. Sunderkoetter. 2012. Induction of an antiinflammatory human monocyte subtype is a unique property of glucocorticoids, but can be modified by IL-6 and IL-10. Immunobiology 217: 329-335.
31. Arya, S. K., F. Wong-Staal, and R. C. Gallo. 1984. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J. Immunol. 133: 273-276.
32. Lee, R. W., T. J. Creed, L. P. Schewitz, P. V. Newcomb, L. B. Nicholson, A. D. Dick, and C. M. Dayan. 2007. CD4+CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoids. J. Immunol. 179: 7941-7948.
33. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
34. Baeten, D., A. M. Boots, P. G. Steenbakkers, D. Elewaut, E. Bos, G. F. Verheijden, G. Berheijden, A. M. Miltenburg, A. W. Rijnders, E. M. Veys, and F. De Keyser. 2000. Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum. 43: 1233-1243.
35. Zhong, H., W. Bao, X. Li, A. Miller, C. Seery, N. Haq, J. Bussel, and K. Yazdanbakhsh. 2012. CD16+ monocytes control T-cell subset development in immune thrombocytopenia. Blood 120: 3326-3335.
36. Ziegler-Heitbrock, H. W. 1996. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol. Today 17: 424-428.
37. Skinner, N. A., C. M. MacIsaac, J. A. Hamilton, and K. Visvanathan. 2005. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Clin. Exp. Immunol. 141: 270-278.
38. Martinez, F. O. 2009. The transcriptome of human monocyte subsets begins to emerge. J. Biol. 8: 99.
39. Zizzo, G., and P. L. Cohen. 2013. IL-17 stimulates differentiation of human antiinflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J. Immunol. 190: 5237-5246.
40. Vallelian, F., C. A. Schaer, T. Kaempfer, P. Gehrig, E. Duerst, G. Schoedon, and D. J. Schaer. 2010. Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity. Blood 116: 5347-5356.
41. Gillis, S., G. R. Crabtree, and K. A. Smith. 1979. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogeninduced lymphocyte proliferation. J. Immunol. 123: 1624-1631.
42. Nowell, P. C. 1961. Inhibition of human leukocyte mitosis by prednisolone in vitro. Cancer Res. 21: 1518-1521.
43. Movahedi, K., M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233-4244.
44. Serbina, N. V., T. Jia, T. M. Hohl, and E. G. Pamer. 2008. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26: 421-452.
45. Belge, K. U., F. Dayyani, A. Horelt, M. Siedlar, M. Frankenberger, B. Frankenberger, T. Espevik, and L. Ziegler-Heitbrock. 2002. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168: 3536-3542.
46. Cros, J., N. Cagnard, K. Woollard, N. Patey, S. Y. Zhang, B. Senechal, A. Puel, S. K. Biswas, D. Moshous, C. Picard, et al. 2010. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33: 375-386.
47. Rivier, A., J. Pène, H. Rabesandratana, P. Chanez, J. Bousquet, and A. M. Campbell. 1995. Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages. Clin. Exp. Immunol. 100: 314-318.
48. Ziegler-Heitbrock, H. W., G. Fingerle, M. Ströbel, W. Schraut, F. Stelter, C. Schütt, B. Passlick, and A. Pforte. 1993. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 23: 2053-2058.